Europe

Obtain the latest insights on mesothelioma clinical trials in Europe. Should you be doing chemotherapy or holistic instead? Learn More

Biopsy | Diagnosis | Europe | International | New Studies | New Techniques | Research

Cellular Factors Predict Survival in Epithelioid Mesothelioma Patients
ByAlex Strauss April 13, 2017August 26, 2019

A team of French scientists believe they have found a way to predict survival and help plan a treatment course…

Read More Cellular Factors Predict Survival in Epithelioid Mesothelioma Patients
Chemotherapy | Europe | International | New Drugs | New Studies | Prognosis | Research | Treatments

New Combination Treatment for Rare Mesothelioma Subtypes
ByAlex Strauss April 10, 2017May 10, 2017

An enzyme shown to help fight melanoma and liver cancer may offer new hope to patients with some of the…

Read More New Combination Treatment for Rare Mesothelioma Subtypes
Biomarkers | Diagnosis | Europe | International | New Studies | Prognosis | Research | Updates

Diagnosing Pleural Mesothelioma with Lung Fluid: The Battle of the Biomarkers
ByAlex Strauss March 21, 2017April 12, 2017

A biomarker called soluble mesothelin related peptide (SMRP) may be a more reliable way to diagnose malignant pleural mesothelioma from…

Read More Diagnosing Pleural Mesothelioma with Lung Fluid: The Battle of the Biomarkers
Europe | International | New Studies | Prognosis | Research | Surgery | Treatments

Radical Mesothelioma Surgery Deemed Not “Clinically Effective”
ByAlex Strauss March 9, 2017March 16, 2017

The heads of a European working group charged with advising cardio-thoracic surgeons on the best ways to treat malignant pleural…

Read More Radical Mesothelioma Surgery Deemed Not “Clinically Effective”
Asbestos | Compensation | Europe | International | Prevention | Statistics

Mesothelioma Risk in Older School Buildings
ByAlex Strauss March 4, 2017March 16, 2017

A new government report has some sobering news for teachers and students in England: Nearly 20 percent of schools may…

Read More Mesothelioma Risk in Older School Buildings
Diagnosis | Europe | International | New Techniques | Symptoms | Treatments | Updates

Shoulder Pain: An Early Symptom of Mesothelioma?
ByAlex Strauss March 3, 2017March 26, 2019

There is new evidence that mesothelioma can affect more than just the part of the body where a tumor occurs.…

Read More Shoulder Pain: An Early Symptom of Mesothelioma?
Europe | Immune Systems | Immunotherapy | International | Multi-Modality Therapy | Research | Treatments | Updates

Immunotherapy for Pleural Mesothelioma: Does it Work?
ByAlex Strauss February 27, 2017March 16, 2017

Immunotherapy is an important emerging therapeutic strategy for several types of cancer, but the jury is still out on whether…

Read More Immunotherapy for Pleural Mesothelioma: Does it Work?
Alternatives | Asbestos | Europe | International | New Drugs | Treatments | Updates

Spice Compound Extends Mesothelioma Survival in Mice
ByAlex Strauss February 22, 2017March 16, 2017

The compound that gives the spice turmeric its yellow color and pungent flavor is once again attracting the attention of…

Read More Spice Compound Extends Mesothelioma Survival in Mice
Asbestos | Europe | International | New Drugs | New Studies | Prognosis | Research | Treatments | Updates

Scoring Tool Helps Doctors Select Mesothelioma Patients for Clinical Trials
ByAlex Strauss February 20, 2017March 16, 2017

Researchers in London have developed a new way of categorizing patients with advanced malignant mesothelioma that allows them to predict…

Read More Scoring Tool Helps Doctors Select Mesothelioma Patients for Clinical Trials
Biomarkers | Diagnosis | Europe | Genetics | International | Prognosis | Research | Updates

BAP1 May Be Valuable for Peritoneal Mesothelioma Prognosis
ByAlex Strauss January 13, 2017March 16, 2017

There is new evidence that the same genetic mutation that is common in people with pleural mesothelioma may be present…

Read More BAP1 May Be Valuable for Peritoneal Mesothelioma Prognosis

1 (888) 378-1331

Europe

Cellular Factors Predict Survival in Epithelioid Mesothelioma Patients

New Combination Treatment for Rare Mesothelioma Subtypes

Diagnosing Pleural Mesothelioma with Lung Fluid: The Battle of the Biomarkers

Radical Mesothelioma Surgery Deemed Not “Clinically Effective”

Mesothelioma Risk in Older School Buildings

Shoulder Pain: An Early Symptom of Mesothelioma?

Immunotherapy for Pleural Mesothelioma: Does it Work?

Spice Compound Extends Mesothelioma Survival in Mice

Scoring Tool Helps Doctors Select Mesothelioma Patients for Clinical Trials

BAP1 May Be Valuable for Peritoneal Mesothelioma Prognosis

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES